NC
WST icon

North Capital’s West Pharmaceutical WST Stock Holding History

North Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9
Closed -$2.36K – 701
2025
Q3 		$2.36K Hold
9
– – ﹤0.01% 510
2025
Q2 		$1.97K Hold
9
– – ﹤0.01% 514
2025
Q1 		$2.02K Buy
+9
New +$2.48K ﹤0.01% 500

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

North Capital's WST Position: Q4 2025 in Review

North Capital sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 9 shares — an estimated $2.36K sold.

North Capital first reported a position in WST in Q1 2025 and held it in 3 quarters. The position peaked at $2.36K in Q3 2025. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • North Capital reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • North Capital sold 9 West Pharmaceutical shares in Q4 2025, an estimated $2.36K.
  • North Capital first reported a position in West Pharmaceutical in Q1 2025 and held it in 3 quarters.
  • North Capital's West Pharmaceutical position peaked at $2.36K in Q3 2025.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.